You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
Moodys
McKinsey
Baxter
Express Scripts

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

CLINDAMYCIN PHOSPHATE AND TRETINOIN Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Clindamycin Phosphate And Tretinoin patents expire, and when can generic versions of Clindamycin Phosphate And Tretinoin launch?

Clindamycin Phosphate And Tretinoin is a drug marketed by Actavis Mid Atlantic and is included in one NDA.

The generic ingredient in CLINDAMYCIN PHOSPHATE AND TRETINOIN is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.

Summary for CLINDAMYCIN PHOSPHATE AND TRETINOIN
Drug patent expirations by year for CLINDAMYCIN PHOSPHATE AND TRETINOIN
Recent Clinical Trials for CLINDAMYCIN PHOSPHATE AND TRETINOIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Haining Health-Coming Biotech Co., Ltd.Phase 2
Zeichner, Joshua, M.D.Phase 4
Actavis Mid-Atlantic LLCN/A

See all CLINDAMYCIN PHOSPHATE AND TRETINOIN clinical trials

Pharmacology for CLINDAMYCIN PHOSPHATE AND TRETINOIN

US Patents and Regulatory Information for CLINDAMYCIN PHOSPHATE AND TRETINOIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Mid Atlantic CLINDAMYCIN PHOSPHATE AND TRETINOIN clindamycin phosphate; tretinoin GEL;TOPICAL 202564-001 Jun 12, 2015 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
Baxter
Colorcon
AstraZeneca
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.